Scottish RSV Vaccine Reduces Hospitalization by 62% for Older Adults

by Archynetys Health Desk






RSV Vaccine Shows Promise in Reducing Hospitalizations Among Older Adults


Getty Images Generic picture of an older lady - with grey hair in a bob and a lilac t-shirt on - being given a jab by a medic in blue plastic gloves.
Getty Images

Hospitalizations for older people were reduced by 62% among 75-79-year-olds

A new vaccination program in Scotland has significantly reduced hospital stays among the elderly, protecting them from a dangerous respiratory disease.

The RSV (Respiratory syncytial virus) vaccine was first administered in Scotland in August. Health Secretary Neil Gray welcomed the results, stating that the Scottish government had invested £4.2 million to support health boards in implementing the vaccine program.


PA Media Health Secretary Neil Gray, wearing a dark suit, pink shirt and navy tie, is pictured in a medical setting - posters on the walls behind him blurred.
PA Media

Neil Gray urged people to take up the jab if offered it

RSV primarily affects the respiratory system and can cause severe illness in vulnerable groups, including infants and elderly individuals.

In the 2022-23 season, over 1,500 infants under one year old and more than 500 people aged 75 and above were hospitalized due to RSV. Across the UK, the respiratory illness results in 25-30 infant deaths annually.

While symptoms are often mild for many, the virus spreads easily among children, with 90% contracting it within the first two years of life.

Significant Reduction in Hospitalizations Among Older Adults

According to Public Health Scotland, the RSV vaccine had a substantial impact on the older population eligible for vaccination. By November’s end, 68% of eligible older adults had received the RSV jab, leading to a significant reduction in hospital admissions.

Health Secretary Neil Gray praised the success of the program, emphasizing the vital role vaccinations play in preventing serious illnesses and minimizing hospital stays. “We were pleased to be the first to introduce the new RSV vaccine in the UK, maximizing its benefit for vulnerable populations ahead of winter,” he stated.

Dr. Sam Ghebrehewet, head of immunization and vaccination at Public Health Scotland, echoed Gray’s sentiments. “The success of the RSV program represents a significant step towards safeguarding the Scottish population against preventable diseases,” he noted.

Understanding RSV and Its Symptoms

Respiratory syncytial virus, commonly known as RSV, is a highly contagious viral infection affecting the breathing system.

RSV symptoms usually appear a few days after infection and can include:

  • A runny or blocked nose
  • Sneezing
  • A cough
  • Tiredness
  • A high temperature

Newborns and infants with RSV may exhibit signs such as irritability and reduced appetite.

For some individuals, RSV can lead to more severe respiratory conditions like bronchiolitis, causing symptoms such as:

  • A worsening cough
  • Rapid and labored breathing
  • Difficulty feeding or swallowing
  • Noisy breathing or wheezing

Related Posts

Leave a Comment